JY
RVMDW icon

Jeff Yass’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Jeff Yass’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,617
Closed -$16.6K – 13985
2025
Q4 		$16.6K Buy
+17,617
New +$9.93K ﹤0.01% 11992

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Jeff Yass's RVMDW Position: Q1 2026 in Review

Jeff Yass sold out of Revolution Medicines Inc Warrant (RVMDW) in Q1 2026, closing a stake of 17,617 shares — an estimated $16.6K sold.

Jeff Yass first reported a position in RVMDW in Q4 2025 and held it in 1 quarter. The position peaked at $16.6K in Q4 2025. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Jeff Yass reported no remaining Revolution Medicines Inc Warrant position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 17,617 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $16.6K.
  • Jeff Yass first reported a position in Revolution Medicines Inc Warrant in Q4 2025 and held it in 1 quarter.
  • Jeff Yass's Revolution Medicines Inc Warrant position peaked at $16.6K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.